Genomic profiling of lung tumors helps choosing most effective treatment

Armen Hareyan's picture
Advertisement

Lung cancer treatment research

Advertisement

Determining the genetic profile of a particular lung tumor can help clinicians make the crucial decision about which chemotherapy treatment to try first for lung cancers.

A new study led by researchers from the Duke University Comprehensive Cancer Center and the Duke Institute for Genome Sciences & Policy (IGSP) found distinct differences in the susceptibility different tumors have to widely used chemotherapy drugs.

Advertisement